搜索
NovaBay Pharmaceuticals Inc
NBY添加自选
1.950USD
0.0000.00%
收盘 07/02, 13:00（美东）报价延迟15分钟
68.61M总市值
亏损市盈率 TTM
关于 NovaBay Pharmaceuticals Inc 公司
NovaBay Pharmaceuticals, Inc. is engaged in wound care products. The Company manufactures and sells its proprietary form of hypochlorous acid for the wound care market through its NeutroPhase and PhaseOne branded products. NeutroPhase and PhaseOne are used for cleansing and irrigation as part of surgical procedures, as well as treating wounds, burns, ulcers and other injuries.
NovaBay Pharmaceuticals Inc简介
公司代码NBY
公司名称NovaBay Pharmaceuticals Inc
上市日期Oct 26, 2007
CEOKazley (Michael John)
员工数量14
证券类型Ordinary Share
年结日Oct 26
公司地址2000 Powell St Ste 1150
城市EMERYVILLE
上市交易所NASDAQ OMX – NASDAQ Basic Amex
国家United States of America
邮编94608-1804
电话15108998800
网址https://novabay.com/
公司代码NBY
上市日期Oct 26, 2007
CEOKazley (Michael John)
NovaBay Pharmaceuticals Inc公司高管
名称
名称/职务
职务
持股
持股变动
Ms. Swan Sit
Ms. Swan Sit
Independent Director
Independent Director
172.00
-10.47%
Mr. Tommy Law
Mr. Tommy Law
Chief Financial Officer, Treasurer
Chief Financial Officer, Treasurer
6.00
+16.67%
Mr. Paul E. Freiman, Ph.D.
Mr. Paul E. Freiman, Ph.D.
Director
Director
--
--
Mr. Justin M. Hall, Esq.
Mr. Justin M. Hall, Esq.
Vice President - Business Development, General Counsel, Corporate Secretary
Vice President - Business Development, General Counsel, Corporate Secretary
--
--
Dr. Yenyou (Jeff) Zheng, Ph.D.
Dr. Yenyou (Jeff) Zheng, Ph.D.
Independent Director
Independent Director
--
--
Capt. Jody Cain
Capt. Jody Cain
IR Contact Officer
IR Contact Officer
--
--
Mr. Michael Kazley
Mr. Michael Kazley
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
--
--
名称
名称/职务
职务
持股
持股变动
Ms. Swan Sit
Ms. Swan Sit
Independent Director
Independent Director
172.00
-10.47%
Mr. Tommy Law
Mr. Tommy Law
Chief Financial Officer, Treasurer
Chief Financial Officer, Treasurer
6.00
+16.67%
Mr. Paul E. Freiman, Ph.D.
Mr. Paul E. Freiman, Ph.D.
Director
Director
--
--
Mr. Justin M. Hall, Esq.
Mr. Justin M. Hall, Esq.
Vice President - Business Development, General Counsel, Corporate Secretary
Vice President - Business Development, General Counsel, Corporate Secretary
--
--
Dr. Yenyou (Jeff) Zheng, Ph.D.
Dr. Yenyou (Jeff) Zheng, Ph.D.
Independent Director
Independent Director
--
--
Capt. Jody Cain
Capt. Jody Cain
IR Contact Officer
IR Contact Officer
--
--
常见问题
NovaBay Pharmaceuticals Inc的前五大股东是谁？
NovaBay Pharmaceuticals Inc 的前五大股东如下：Ms. Swan Sit
有多少机构持有NovaBay Pharmaceuticals Inc(NBY)的股份？
截至2026Q1，共有47家机构持有NovaBay Pharmaceuticals Inc的股份，合计持有的股份价值约为1.80M，占公司总股份的6.77%。与2025Q4相比，机构持股有所增加，增幅为1464094.00。